Zoetis Inc.
ZTS
#795
Rank
$32.033 B
Marketcap
United States
Country
$77.52
Share price
2.88%
Change (1 day)
-50.37%
Change (1 year)
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including…
Key Metrics
Trailing P/E
11.91
Forward P/E
11.18
EPS (TTM)
$6.13
Forward EPS
$6.53
Price / Book
—
EV / EBITDA
9.3x
Beta
0.73
Dividend Yield
2.90%
Return on Equity
64.91%
Return on Assets
15.35%
Debt / Equity
294.00
Current Ratio
3.08
Gross Margin
71.74%
Operating Margin
40.72%
Net Profit Margin
27.68%
Free Cash Flow
$2.017B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 16
-4.80%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$9.467B
Latest Net Income$2.673B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Zoetis Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
ZTS
No recent news available. Set FINNHUB_API_KEY to enable news.
